IntelliCell BioSciences, Inc. (OTC: SVFC) is a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. The company is also exploring technology-licensing agreements with technology developers, universities, and international business entities. For more information, visit the company’s website at www.intellicellbiosciences.com